Amicus Therapeutics, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
FOLD Nasdaq 8731 https://www.amicusrx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amicus Therapeutics, Inc.

7 Stocks Most Likely to Follow in WeWork’s Woeful Footsteps - Nov 15th, 2023 2:48 pm
Amicus Therapeutics, Inc. (NASDAQ:FOLD): Are Analysts Optimistic? - Nov 11th, 2023 2:12 pm
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q3 2023 Earnings Call Transcript - Nov 10th, 2023 3:07 pm
Amicus' (FOLD) Q3 Loss Narrows, Galafold Sales View Updated - Nov 9th, 2023 6:02 pm
Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates - Nov 8th, 2023 12:00 pm
Insider Sell: Amicus Therapeutics Inc President and CEO Bradley Campbell Sells 11,700 Shares - Nov 4th, 2023 9:03 am
Synlogic, Inc. (SYBX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Nov 2nd, 2023 2:00 pm
Amicus Therapeutics (FOLD) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Nov 1st, 2023 2:01 pm
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023 - Nov 1st, 2023 11:00 am
Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023 - Oct 27th, 2023 11:00 am
This Rare Disease Pharma Is a Hidden Gem - Oct 8th, 2023 11:00 am
‘Stay Invested Through the Uncertainty’: J.P. Morgan Says Stocks Could Reach New Highs Next Year — Here Are 2 Names to Pounce on Now - Oct 5th, 2023 11:45 pm
Insider Sell: Amicus Therapeutics Inc President & CEO Bradley Campbell Sells 11,700 Shares - Oct 5th, 2023 7:01 am
Amicus Therapeutics Announces Presentation and Posters at World Muscle Society 2023 - Oct 3rd, 2023 11:00 am
Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration - Oct 2nd, 2023 12:20 pm
Amicus (FOLD) Gets FDA Approval for Pompe Disease Drug - Sep 29th, 2023 1:09 pm
UPDATE 1-US FDA approves Amicus Therapeutics' muscle disorder treatment - Sep 28th, 2023 3:08 pm
Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease - Sep 28th, 2023 2:41 pm
Amicus Therapeutics Stock Reaches 80+ Relative Strength Benchmark - Sep 28th, 2023 2:32 pm
Zacks.com featured highlights include Amicus Therapeutics, Genius Sports and Viad - Sep 21st, 2023 12:42 pm